Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ti.\*:("Infectious diseases: Basel research forum international")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Infectious diseases: Basel research forum internationalGLAUSER, Michel P.Drugs (Basel). 1996, Vol 52, issn 0012-6667, 114 p., SUP2Conference Proceedings

The appropriate use of quinolonesPERCIVAL, A.Drugs (Basel). 1996, Vol 52, pp 34-36, issn 0012-6667, SUP2Conference Paper

Use of antimicrobials in Swiss hospitalsLEW, D. P; GARBINO, J; GERBER, A. U et al.Drugs (Basel). 1996, Vol 52, pp 88-91, issn 0012-6667, SUP2Conference Paper

Antibiotic policies : Economics and effectiveness from a UK perspectiveDAVEY, P.Drugs (Basel). 1996, Vol 52, pp 83-87, issn 0012-6667, SUP2Conference Paper

Chronic obstructive pulmonary disease : Mortality and mortality reduction. DiscussionFIEL, S. B; PELTON, S; DURACK, D. T et al.Drugs (Basel). 1996, Vol 52, pp 55-61, issn 0012-6667, SUP2Conference Paper

Interleukin-12 : Potential clinical applications in the treatment and prevention of infectious diseases. DiscussionGATELY, M. K; MULQUEEN, M. J; DURACK, D. T et al.Drugs (Basel). 1996, Vol 52, pp 18-26, issn 0012-6667, SUP2Conference Paper

The challenge of changing healthcare systems. DiscussionWEBER, F; GLAUSER, M. P; HOIBY, N et al.Drugs (Basel). 1996, Vol 52, pp 68-77, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of multiresistant gram-negative rods. DiscussionWIEDEMANN, B; FINCH, R. G; GLAUSER, M. P et al.Drugs (Basel). 1996, Vol 52, pp 95-102, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. DiscussionPETERS, G; BECKER, K.Drugs (Basel). 1996, Vol 52, pp 50-54, issn 0012-6667, SUP2Conference Paper

Pathophysiology and treatment of hepatitis C. DiscussionTHOMAS, H. C; BOOTH, J; BROWN, J et al.Drugs (Basel). 1996, Vol 52, pp 1-8, issn 0012-6667, SUP2Conference Paper

Antibiotic usage : Pharmacoeconomic impact in a changing healthcare systemMILKOVICH, G.Drugs (Basel). 1996, Vol 52, pp 80-82, issn 0012-6667, SUP2Conference Paper

Antibiotic usage : Policy, clinical and pharmacoeconomic outcomesCARBON, C.Drugs (Basel). 1996, Vol 52, pp 78-79, issn 0012-6667, SUP2Conference Paper

Epidemiology and control of multiresistant enterococci. DiscussionLECLERCQ, R; MUKHTAR, A. H; HOIBY, N et al.Drugs (Basel). 1996, Vol 52, pp 47-49, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of multidrug-resistant tuberculosisCHAULET, P; RAVIGLIONE, M; BUSTREO, F et al.Drugs (Basel). 1996, Vol 52, pp 103-108, issn 0012-6667, SUP2Conference Paper

Epidemiology, control and treatment of multiresistant pneumococci. DiscussionKLUGMAN, K. P; MUKHTAR, A. H; SCHAAD, U. B et al.Drugs (Basel). 1996, Vol 52, pp 42-46, issn 0012-6667, SUP2Conference Paper

Fluoroquinolones in urinary tract infections : Proper and improper useNABER, K. G.Drugs (Basel). 1996, Vol 52, pp 27-33, issn 0012-6667, SUP2Conference Paper

The inflammatory cytokines : New developments in the pathophysiology and treatment of septic shock. DiscussionGLAUSER, M. P; DURACK, D. T.Drugs (Basel). 1996, Vol 52, pp 9-17, issn 0012-6667, SUP2Conference Paper

New concepts in the pathophysiology and management of middle ear disease in childhood. DiscussionPELTON, S. I; KUNGU, C; GLAUSER, M. P et al.Drugs (Basel). 1996, Vol 52, pp 62-67, issn 0012-6667, SUP2Conference Paper

  • Page / 1